Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

National utilization of calcium supplements in patients with osteoporotic hip fracture in Korea.

Kim SH, Ko YB, Lee YK, Hong SW, Choi HJ, Ha YC, Shin CS.

J Bone Metab. 2013 Nov;20(2):99-103. doi: 10.11005/jbm.2013.20.2.99. Epub 2013 Nov 18.

2.

Bisphosphonate use and subsequent hip fracture in South Korea.

Lee YK, Ha YC, Choi HJ, Jang S, Park C, Lim YT, Shin CS.

Osteoporos Int. 2013 Nov;24(11):2887-92. doi: 10.1007/s00198-013-2395-5. Epub 2013 May 17.

PMID:
23681088
3.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

4.

Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.

Nurmi-Lüthje I, Lüthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, Karjalainen K.

Drugs Aging. 2009;26(5):409-21. doi: 10.2165/00002512-200926050-00005.

PMID:
19552493
5.

Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry.

Yoon HK, Lee YK, Ha YC.

J Bone Metab. 2017 Feb;24(1):59-63. doi: 10.11005/jbm.2017.24.1.59. Epub 2017 Feb 28.

6.

Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry.

Lee YK, Ha YC, Park C, Yoo JJ, Shin CS, Koo KH.

Osteoporos Int. 2013 Feb;24(2):707-11. doi: 10.1007/s00198-012-2016-8. Epub 2012 May 23.

PMID:
22618268
7.

Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.

Castro-Lionard K, Dargent-Molina P, Fermanian C, Gonthier R, Cassou B.

Drugs Aging. 2013 Dec;30(12):1029-38. doi: 10.1007/s40266-013-0121-9.

PMID:
24114665
8.

Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients.

Hsu CY, Chiu WC, Chen JF, Chou CL, Su YJ, Yu SF, Cheng TT.

J Bone Miner Metab. 2015 Sep;33(5):577-83. doi: 10.1007/s00774-014-0621-7. Epub 2014 Sep 21.

PMID:
25240801
9.

Mortality after vertebral fracture in Korea: analysis of the National Claim Registry.

Lee YK, Jang S, Jang S, Lee HJ, Park C, Ha YC, Kim DY.

Osteoporos Int. 2012 Jul;23(7):1859-65. doi: 10.1007/s00198-011-1833-5. Epub 2011 Nov 23.

PMID:
22109741
10.

Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data.

Kang HY, Yang KH, Kim YN, Moon SH, Choi WJ, Kang DR, Park SE.

BMC Public Health. 2010 May 4;10:230. doi: 10.1186/1471-2458-10-230.

11.
12.

Low incidence of anti-osteoporosis treatment after hip fracture.

Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY.

J Bone Joint Surg Am. 2008 Oct;90(10):2142-8. doi: 10.2106/JBJS.G.00864.

13.
14.

The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan.

Chang CY, Tang CH, Chen KC, Huang KC, Huang KC.

Osteoporos Int. 2016 Feb;27(2):665-76. doi: 10.1007/s00198-015-3238-3. Epub 2015 Aug 5.

PMID:
26243356
15.

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S.

Mayo Clin Proc. 2006 Aug;81(8):1013-22.

PMID:
16901023
16.
17.

GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates.

Hadji P, Claus V, Ziller V, Intorcia M, Kostev K, Steinle T.

Osteoporos Int. 2012 Jan;23(1):223-31. doi: 10.1007/s00198-011-1535-z. Epub 2011 Feb 10.

PMID:
21308365
18.

Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.

Avenell A, Mak JC, O'Connell D.

Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227. doi: 10.1002/14651858.CD000227.pub4. Review.

PMID:
24729336
19.

Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.

Chang KP, Center JR, Nguyen TV, Eisman JA.

J Bone Miner Res. 2004 Apr;19(4):532-6. Epub 2004 Jan 5.

20.

Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.

Cheng LI, Durden E, Limone B, Radbill L, Juneau PL, Spangler L, Mirza FM, Stolshek BS.

J Manag Care Spec Pharm. 2015 Sep;21(9):824-33, 833a.

Supplemental Content

Support Center